Dr. Jerome Adams Joins Eko Health as Distinguished Medical Advisor
Eko Health, a pioneering force in artificial intelligence-driven cardiac and pulmonary detection, has recently welcomed Dr. Jerome Adams, MD, MPH, FASA as their Distinguished Medical Advisor. Dr. Adams, who previously served as the U.S. Surgeon General, brings extensive experience in clinical practice, public health, and policy to the role, which he assumes during a period of significant growth for the company.
Dr. Adams expressed his pride in joining Eko at such a pivotal time. He noted, "Eko is transforming how we detect cardiovascular disease by making cutting-edge, AI-powered tools accessible to frontline providers in communities that need them most. This is how we can close gaps in care and improve patient outcomes—ultimately saving lives."
During his tenure as Surgeon General, Dr. Adams issued impactful advisories emphasizing maternal health and hypertension, two key contributors to adverse cardiovascular outcomes, particularly in underserved areas. These areas resonate with Eko's mission of empowering early, AI-based detection tools on the frontline of healthcare, where timely interventions are crucial. Additionally, Dr. Adams took significant steps in addressing the opioid crisis and promoting the connection between community health and economic prosperity.
In his newly-appointed role at Eko, Dr. Adams will play a crucial part in guiding clinical implementation, product development, and building public health partnerships. His focus is on making high-performance cardiac screening affordable and accessible, enhancing the potential for earlier and more accurate detection in primary care settings that have historically lacked access to specialist-level interventions.
The CEO of Eko Health, Connor Landgraf, commended Dr. Adams' multifaceted experience. He stated, "Dr. Adams brings an exceptional combination of clinical insight, government leadership, and public health experience. His understanding of how to transform medical innovation into tangible impact will be invaluable as we expand the reach of our AI-enabled medical devices."
Alongside his duties at Eko, Dr. Adams serves as a Distinguished Professor of Practice in Pharmacy Practice and Public Health at Purdue University. His previous advisories, addressing naloxone usage in the face of the opioid epidemic, promoting maternal health, and hypertension control, reflect his commitment to public health.
Under Dr. Adams’ expertise, Eko is intensifying its dedication to clinical excellence and the expansion of health equity on a global scale. Research indicates that Eko's technology could significantly enhance the early detection of congenital heart diseases, especially in resource-limited settings, ensuring that children with critical conditions receive the care they need promptly. For instance, a clinical trial conducted in Nigeria showcased the effectiveness of Eko's platform in identifying peripartum cardiomyopathy among pregnant women.
In the U.S., Eko’s collaboration with HeartSense is set to improve access to structural heart disease detection, particularly within underserved communities. This partnership aims to provide healthcare practitioners with actionable insights, revolutionizing how care is delivered to these patients.
Eko Health continues to lead pioneering efforts in early disease detection, transforming how healthcare professionals assess and manage heart and lung diseases. With an impressive portfolio that includes digital stethoscopes, ECG devices, and AI-powered analytics, Eko's FDA-cleared platform already boasts over 650,000 devices distributed globally. These innovations empower healthcare providers to improve early detection, effectively manage treatment, and ultimately deliver superior patient care.
In summary, Dr. Jerome Adams’ appointment strengthens Eko Health’s commitment to enhancing health outcomes through innovative technology. By leveraging AI, Eko aims to bridge the care gap and democratize access to essential health services, paving the way for a healthier future across communities.
For further information about Eko Health and its advancements, please visit
ekohealth.com.